Artificial Intelligence (AI) in Clinical Trials Market worth $4.8 billion by 2027 - Exclusive Report by MarketsandMarkets

CHICAGO, Oct. 25, 2022 /PRNewswire/ -- Artificial Intelligence (AI) in Clinical Trials Market is projected to reach USD 4.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 25.6% during

Related Keywords

United States ,Canada ,Northbrook ,Illinois ,Chicago ,America ,Kostenloser Wertpapierhandel ,Aashish Mehra ,Koninklijke Philips ,Koneksa Health ,Ibm ,Bioage Labs Inc ,Antidote Technologies Inc ,Unlearn Ai Inc ,Research Reports Consulting ,Halo Health Systems ,Intel ,Clinical Trials Marketis ,Sample Pages ,Saama Technologies ,Insilico Medicine ,Bioage Labs ,Median Technologies ,Antidote Technologies ,Free Customization ,Adjacent Market ,Research Reports ,Care Market ,Information System Market ,Engagement Model ,Artificial ,Intelligence ,Linical ,Trials ,Market ,North ,Billion ,027 ,Exclusive ,Report ,Marketsandmarkets ,